Abstract
Humans exposed to rabies virus must be promptly treated by passive immunization with anti-rabies antibody and active immunization with rabies vaccine. Currently, antibody prepared from pooled human serum or from immunized horses is utilized. However, neither of these reagents are readily available, entirely safe, or consistent in their biological activity. An ideal reagent would consist of a panel of human monoclonal antibodies. Such antibodies are now available, their only drawback being the cost of production. Using recombinant technology, we constructed a rabies virus-based vector which expresses high levels (approximately 60 pg/cell) of rabies virus-neutralizing human monoclonal antibody. The vector is a modified vaccine strain of rabies virus in which the rabies virus glycoprotein has been replaced with a chimeric vesicular stomatitis virus glycoprotein, and both heavy and light chain genes encoding a human monoclonal antibody have been inserted. This recombinant virus can infect a variety of mammalian cell lines and is non-cytolytic, allowing the use of cell culture technology routinely employed to produce rabies vaccines.
References
Jan 1, 1990·The Journal of Experimental Medicine·Y UekiP Casali
Nov 1, 1988·Reviews of Infectious Diseases·J H Steele
Feb 1, 1989·Vaccine·H WildeS Chutivongse
Aug 1, 1993·Hybridoma·F ArakawaY Matsuoka
Feb 10, 1994·Journal of Immunological Methods·R J Owens, R J Young
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·K MorimotoB Dietzschold
Feb 17, 2000·Journal of Immunological Methods·J M ChampionD C Hooper
Citations
Mar 10, 2010·Biotechnology Letters·Lingling LiuYandao Gong
Jul 30, 2002·The Lancet Infectious Diseases·Charles E RupprechtThiravat Hemachudha
Dec 7, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bishnu P DeJulie L Boyer
Mar 8, 2008·Human Gene Therapy·Masaki WatanabeRonald G Crystal
Jan 7, 2009·Infection and Immunity·Carolina Sofer-PodestaJulie L Boyer
Sep 27, 2003·Journal of Virology·James P McGettiganMatthias J Schnell
Mar 30, 2005·Journal of Virology·Wilfred E MarissenAlexander B H Bakker
Aug 31, 2004·Journal of Clinical Pathology·K A SmithJ Greenman
Nov 6, 2009·PLoS Neglected Tropical Diseases·Thomas MüllerMarie Paule Kieny
Mar 19, 2013·Virus Research·Limin YangWenjun Liu
Sep 24, 2011·Human Vaccines·Anurag SharmaStefan Worgall
Jun 17, 2008·Virology·Davor SkaricicStefan Worgall
Jul 6, 2006·Virology·Mary Ellen SmithMatthias J Schnell
Aug 30, 2014·PloS One·Jean MukherjeeCharles B Shoemaker
Jan 26, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazuhiko KasuyaRonald G Crystal
Apr 16, 2005·The Journal of General Virology·Milosz FaberMatthias J Schnell
Aug 9, 2003·Expert Review of Vaccines·Bernhard DietzscholdMatthias J Schnell